Jikei-Evaluation of basal insulin analogue on (nocturnal) glycaemic variability with continuous glucose monitoring -existing basal insulin analogue versus Tresiba; insulin degludec - a new basal insulin analogue, in basal-bolus treatment in type 2 diabetes

Trial Profile

Jikei-Evaluation of basal insulin analogue on (nocturnal) glycaemic variability with continuous glucose monitoring -existing basal insulin analogue versus Tresiba; insulin degludec - a new basal insulin analogue, in basal-bolus treatment in type 2 diabetes

Completed
Phase of Trial: Phase III

Latest Information Update: 27 Oct 2016

At a glance

  • Drugs Insulin degludec (Primary) ; Insulins
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Acronyms JET-2
  • Most Recent Events

    • 26 Oct 2016 Status changed from recruiting to completed.
    • 29 Apr 2015 Planned End Date changed to 1 Jun 2015 according to University Hospital Medical Information Network - Japan record.
    • 01 Jul 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top